ArticleCancer immunology, immunotherapy : CII2007

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.

Morgan G Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.